Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Read now
Darshan Mehta, Matthew Davis, Andrew J. Epstein, Brian Wensel, Todd Grinnell, Andrew Thach & G. Rhys Williams. (2021) Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD. Journal of Medical Economics 24:1, pages 939-948.
Read now
Read now
Articles from other publishers (13)
Lili Sun, Yuan Liu, Hanxin Song, Jian Hao & Liang Lin. (2023) Engineering of an ene-reductase for producing the key intermediate of antiepileptic drug Brivaracetam. Applied Microbiology and Biotechnology 107:5-6, pages 1649-1661.
Crossref
Crossref
Sophie Naddell, Megan Manuel, Rebecca Cavill, Paul White & Katarzyna Sieradzan. (2023) BRIVEST: A ‘real-world’ observational, single-centre study investigating the efficacy, safety and tolerability of Brivaracetam. Epilepsy & Behavior 138, pages 108985.
Crossref
Crossref
Darshan Mehta, Inyoung Lee, Hangcheng Liu, Mitchell DeKoven, Brian Wensel & G. Rhys Williams. (2022) Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam in the long-term care setting in the USA. Journal of Comparative Effectiveness Research 11:17, pages 1293-1308.
Crossref
Crossref
José Manuel Sánchez-Villalobos, Ángel Aledo-Serrano, Irene Villegas-Martínez, Mohd Farooq Shaikh & Miguel Alcaraz. (2022) Epilepsy treatment in neuro-oncology: A rationale for drug choice in common clinical scenarios. Frontiers in Pharmacology 13.
Crossref
Crossref
Adam Strzelczyk & Susanne Schubert-Bast. (2022) Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. CNS Drugs 36:10, pages 1079-1111.
Crossref
Crossref
Kiwon Lee, Pavel Klein, Prashant Dongre, Eun Jung Choi & Denise H. Rhoney. (2022) Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review. Journal of Intensive Care Medicine 37:9, pages 1133-1145.
Crossref
Crossref
Ersida Buraniqi, Hicham Dabaja & Elaine C. Wirrell. (2022) Impact of Antiseizure Medications on Appetite and Weight in Children. Pediatric Drugs 24:4, pages 335-363.
Crossref
Crossref
Manoj Gayke, Hanuman Narode, Gyanchander Eppa, Rajesh S. Bhosale & Jhillu Singh Yadav. (2022) Synthetic Approaches toward the Synthesis of Brivaracetam: An Antiepileptic Drug. ACS Omega 7:3, pages 2486-2503.
Crossref
Crossref
Chantal Depondt, Wim Van Paesschen, Kenou van Rijckevorsel, Iryna Leunikava & France Ferrière. (2021) Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review. Drugs - Real World Outcomes 8:3, pages 407-415.
Crossref
Crossref
Gajanan Vithoba Panchal & Vijay Nath Mishra. (2021) A brief review on efficacy and safety of brivaracetam in the management of partial onset epilepsy. IP Indian Journal of Neurosciences 7:2, pages 99-105.
Crossref
Crossref
Te-Yu Hung, Sheng-Nan Wu & Chin-Wei Huang. (2021) The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability. Biomedicines 9:4, pages 369.
Crossref
Crossref
Elma M. Paredes-Aragón, Héctor E. Valdéz-Ruvalcaba, Andrea Santos-Peyret, Marcela Cisneros-Otero, Raúl Medina-Rioja, Sandra Orozco-Suárez, Miriam M. Hernandez, Michele D. L. Breda-Yepes, Verónica Rivas-Alonso, José J. Flores-Rivera & Iris E. Martínez-Juárez. (2020) Continuous Visual Focal Status Epilepticus as the Primary Presentation of NMDA-R and GAD65-R Autoimmune Epilepsy. Frontiers in Neurology 11.
Crossref
Crossref
Stephan Arnold, Cédric Laloyaux, Anne-Liv Schulz, Sami Elmoufti, Stephen Yates & Toufic Fakhoury. (2020) Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial. Epilepsy Research 166, pages 106404.
Crossref
Crossref